Conducted global intellectual property due diligence and advised on the transactional elements of a US$60 million equity participation by an international energy company in a U.S. company specializing in biobased chemicals. The collaboration will result in the establishment of bio-succinic acid production plants using natural raw feedstocks such as tapioca, cassava, maize, and other agricultural inputs for the downstream manufacturing of bio-based plastics.
Alan Adcock
Partner and Deputy Director, Intellectual Property
PRACTICE
OFFICE
LANGUAGE
English, Chinese
EDUCATION
JD, Syracuse University College of Law/Columbia Law School
MA, University of Hawai'i
BA, Wingate College
Alan Adcock is a partner and deputy director of the Tilleke & Gibbins intellectual property and regulatory affairs groups, helping to oversee the firm’s client work in these areas across ASEAN. He is known for his “detailed knowledge of the law” (The Legal 500 Asia Pacific 2010/2011), fluency in Mandarin, and outstanding client service. Since 2005, Alan has received recognition by Asialaw Leading Lawyers Survey as one of Asia's leading business lawyers in the area of intellectual property, and he was named a top IP lawyer in Thailand by Chambers Asia-Pacific 2013 and WTR 1000 2013. He is also recognized as one of the world’s leading life sciences practitioners by IAM Life Sciences 250 and PLC Which Lawyer.
Alan represents diverse clients, from pioneers in the life sciences to the biggest IP owners in the world, and helps them achieve the dual goals of profit and protection. He has extensive experience in IP acquisitions, strategic structuring, technology transfer, and IP licensing and securitization agreements. He has handled various IP infringements and regulatory infractions involving labeling, advertising, clinical trials, product handling/warehousing, product registration, taxation, and import/export violations in Thailand, China, Hong Kong, Macau, Japan, South Korea, Malaysia, Indonesia, the Philippines, and Vietnam.
Alan is also closely involved in Tilleke & Gibbins’ leading patent and trade secret litigation practice, focusing mainly on the pharmaceutical, agrochemical, and material science sectors. He handles local pre-litigation strategy and litigation management for infringement and invalidation matters and works regularly with external counsel globally when strategic tasks or evidence issues reach outside Southeast Asia.
Alan is a Co-Chair of the American Chamber of Commerce in Thailand’s Food & AgriBusiness Committee and serves as the Thailand representative on the INTA Legislation & Regulation Committee, East Asia and Pacific Subcommittee.
-
-
Assisted a client with a multijurisdictional acquisition of a major corn and palm oil brand with a deal value of USD 6,000,000, including the review and acceptance of the letter bid, preliminary due diligence, review of the disclosure statement, and the drafting, negotiation, and execution of the main acquisition agreement. We also provided all post-completion follow-up including trademark assignment recordals in more than 50 jurisdictions, release of various title encumbrances, transitional arrangements, rebranding, certification and labeling regulatory advice, and subsequent new agreements for supply and distribution.
-
Helped a multinational food company comply with Thai FDA requirements. Advised the client on advertising and promotional materials in Thailand, with particular emphasis on the requirements of the FDA and the consequences of improper ad content.
-
Acted on behalf of a major U.S.-based agrichemical manufacturer. The case involved termination of the client’s distributor for breach of contract and IP (patent and trademark) infringement. In addition, we represented the client in re-registration of its full range of products with the Thai Ministry of Agriculture.
-
Represented a leading producer of smartphones as its "point of contact" with all government authorities, which involved crafting an overall government relations strategy, establishing and cultivating relationships with officials, responding to government investigations, monitoring potential policy and regulatory developments, and seeking legislative and regulatory change on our client’s behalf. We have also structured appropriate and effective solutions to the business and legal challenges faced by our client.
-
Represented a multinational pharmaceutical company in its cancellation petition against a registered trademark based on the mark’s similarity to an International Nonproprietary Name (INN) issued by the World Health Organization (WHO). The Board of Trademarks withdrew the trademark.
-
Protected the intellectual property rights of a famous drug company in regard to an osteoporosis drug product passed off by another pharmaceutical company. The IP&IT Court ordered the cancellation of the infringing party’s mark and the payment of damages for infringement on a monthly basis, calculated from the date of filing the Complaint.
-
Represented a multinational pharmaceutical company in patent infringement litigation against a local generic company. Managed a major pharmaceutical-related patent during a trial on patent infringement.
-
Acted as counsel to a major pharmaceutical company, which representation included liaising with the Thai FDA on marketing compliance issues, verifying that the client’s marketing activities were in compliance with the complex regulations governing pharmaceutical practice in Thailand, and preventing and mitigating risk and loss.
-
Represented a leading pharmaceutical company on regulatory due diligence in its spin-off of high revenue product lines (over the counter antihistamines, cough relief syrups, tablets and elixirs) to another pharmaceutical company.
-
Represented a multinational cosmetics manufacturer in negotiating a multi-million dollar tri-party agreement between the Department of Agriculture, a local Thai university, and the client to set up a joint research and development program for sourcing and uncovering botanical ingredients in Thailand for their new product range.
Date |
Title |
|---|---|
| March 26, 2012 |
WTR 1000 Ranks Tilleke & Gibbins as a “Gold” Trademark Firm in Thailand World Trademark Review has now released its annual WTR 1000 rankings for 2012, and Tilleke & Gibbins has been rated as a “Gold Band” trademark practice in Thailand, the top ranking that a firm... |
| April 12, 2012 |
IP Group Recognized Among Top Practices in Asia by Asian Legal Business The Tilleke & Gibbins intellectual property team has been recognized among the top 20 IP practices in Asia by Asian Legal Business (ALB). In its recent IP survey, ALB ranked the top IP firms in... |
| May 24, 2012 |
PLC Which Lawyer Ranks Tilleke & Gibbins’ Attorneys in Corporate and M&A, IP, and Tax Piyanuj (Lui) Ratprasatporn, Michael K. Lee, Darani Vachanavuttivong, Alan Adcock, Sriwan Puapondh In PLC Which Lawyer’s 2012 publication, the following Tilleke & Gibbins lawyers have been recommended for their expertise in the relevant practice areas: Practice Jurisdiction Ranked... |
| May 24, 2012 |
Tilleke & Gibbins Named Leading Thai Intellectual Property Firm by PLC In PLC Which Lawyer’s 2012 rankings, Tilleke & Gibbins’ intellectual property team in Thailand has sustained its “Leading” (Tier 1) ranking from in 2012, marking the seventh consecutive year that... |
| May 29, 2012 |
Tilleke & Gibbins Partners Discuss the Thai Pharmaceutical Industry Darani Vachanavuttivong, Tiziana Sucharitkul, Alan Adcock The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to... |
|
Date |
Title |
|---|---|
| July 2, 2008 |
Thailand Pharmaceutical Update Alan Adcock, Siraprapha Rungpry Thailand has quickly become the country to watch in the pharmaceutical field since the Thai Ministry of Public Health (MoPH) stepped in and issued compulsory licenses on various key patented drugs.... |
| September 21, 2008 |
Pharmaceutical Industry in Asia Alan Adcock, Siraprapha Rungpry The development of the pharmaceutical industry in Asia has been influenced by government policies and the growth in the laws and regulatory bodies that oversee various aspects of drug manufacture and... |
| November 8, 2008 |
Alan Adcock In September 2008, China once again found itself at the center of international media attention for all the wrong reasons. Reports circulated that four infants had died and more than 50,000 others... |
| May 15, 2009 |
Graduating from China’s IP Classroom Alan Adcock This article contends that experience in dealing with IP issues in China can provide valuable lessons that are applicable to many other markets. The strategies, experiences, relationships, and ideas... |
| July 6, 2009 |
Outsourcing Product Registration in Asia – Why Expert Assistance Helps! Alan Adcock, Paul G. Russell As most ASEAN Food and Drug Administrations and Ministries of Agriculture labor under critical backlogs of product registration applications for the growing number of products being released into... |
